<DOC>
	<DOC>NCT00283946</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of FK199B (Zolpidem MR Tablet) in patients with insomnia by a randomized, double-blind, group-comparison study using zolpidem (Myslee) as a comparative drug</brief_summary>
	<brief_title>A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Clinical diagnosis of nonorganic insomnia. Must be able to swallow tablets Allergic reactions to zolpidem (Myslee) Serious cardiac disorders; Serious hepatic impairment; Serious renal diseases, etc.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>zolpidem</keyword>
	<keyword>sleep initiation and maintenance disorders Hypnotics and sedatives</keyword>
	<keyword>double-blind study</keyword>
	<keyword>comparative study</keyword>
</DOC>